134 related articles for article (PubMed ID: 11061726)
1. FDA panel advises against omeprazole as over the counter drug.
Gottlieb S
BMJ; 2000 Nov; 321(7269):1099. PubMed ID: 11061726
[No Abstract] [Full Text] [Related]
2. FDA says statin cannot be sold over the counter.
Gottlieb S
BMJ; 2000 Jul; 321(7255):196. PubMed ID: 10903643
[No Abstract] [Full Text] [Related]
3. Switching prescription drugs to over the counter.
Cohen JP; Paquette C; Cairns CP
BMJ; 2005 Jan; 330(7481):39-41. PubMed ID: 15626806
[TBL] [Abstract][Full Text] [Related]
4. Panel recommends limits on alcohol content of nonprescription products. FDA Over-The-Counter Drugs Advisory Committee.
Am J Hosp Pharm; 1993 Mar; 50(3):400. PubMed ID: 8442445
[No Abstract] [Full Text] [Related]
5. FDA rejects sale of over the counter statins.
Dyer O
BMJ; 2005 Jan; 330(7484):164. PubMed ID: 15661770
[No Abstract] [Full Text] [Related]
6. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Aug; 65(168):52302-5. PubMed ID: 11067736
[TBL] [Abstract][Full Text] [Related]
7. FDA launches campaign on OTC pain relief products.
FDA Consum; 2004; 38(2):8. PubMed ID: 15101357
[TBL] [Abstract][Full Text] [Related]
8. No doctor required. The FDA may expand the number of prescription drugs it converts to over-the-counter use.
Thompson M
Time; 2000 Jul; 156(3):38. PubMed ID: 11009720
[No Abstract] [Full Text] [Related]
9. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
Food and Drug Administration, HHS
Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
[TBL] [Abstract][Full Text] [Related]
10. Potential effect of over-the-counter sales on omeprazole calls to Texas poison centers.
Forrester MB
Tex Med; 2007 Jun; 103(6):48-51. PubMed ID: 17624128
[No Abstract] [Full Text] [Related]
11. The FDA approves new over-the-counter sunscreen.
FDA Consum; 2006; 40(5):4. PubMed ID: 17326301
[No Abstract] [Full Text] [Related]
12. The FDA takes action against unapproved drugs.
Meadows M
FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
[TBL] [Abstract][Full Text] [Related]
13. FDA panel vetoes OTC version of cholesterol drug.
Walczak IM
Diabetes Technol Ther; 2000; 2(3):484. PubMed ID: 11467353
[No Abstract] [Full Text] [Related]
14. FDA ducks decision on emergency contraceptive.
Tanne JH
BMJ; 2005 Sep; 331(7517):596. PubMed ID: 16166131
[No Abstract] [Full Text] [Related]
15. FDA agrees to ease restrictions on emergency contraceptive.
Tanne JH
BMJ; 2009 Apr; 338():b1756. PubMed ID: 19401315
[No Abstract] [Full Text] [Related]
16. FDA considers implementing behind-the-counter system.
Sipkoff M
Manag Care; 2008 May; 17(5):17-8. PubMed ID: 18567463
[No Abstract] [Full Text] [Related]
17. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Feb; 67(27):5942-3. PubMed ID: 11837282
[TBL] [Abstract][Full Text] [Related]
18. FDA is told to ease restrictions on morning after pill.
Tanne JH
BMJ; 2009 Mar; 338():b1313. PubMed ID: 19329526
[No Abstract] [Full Text] [Related]
19. Pediculicide drug products for over-the-counter human use; amendment of final monograph. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2003 Dec; 68(250):75414-8. PubMed ID: 14986677
[TBL] [Abstract][Full Text] [Related]
20. [Over-the-counter drugs, subsidy and safety].
Kampmann JP
Ugeskr Laeger; 1991 May; 153(20):1401-2. PubMed ID: 1674178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
